⌕
10x Genomics · TXG · Nasdaq
Tenet 54 · Mixed
Compare
$58.19−1.54%At closeTenet 54 · Mixed
$58.19−0.91 (−1.54%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

10x Genomics (TXG) Stock

10x Genomics (TXG) closed at $58.19 on Nov 13, 2026; its Tenet Score is 54 of 100 against 483 Technology peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$58.19
Nov 13, 2026
Market cap
$7.7B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
15.12 – 102.81
low → high
Tenet Score
54/100
Mixed · 483 Technology peers

Industry: Health Services · see every company filed here →

10x Genomics Inc scores 54/100. Mixed. Strongest on financial health and growth, value is the soft spot versus 483 Technology peers.

Tenet Score · vs sector

n=483
54/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
20
Quality
38
Health
91
Growth
66

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthAGrowthCMomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
9.1×
price to book value
P/S
12.4×
price to fiscal 2025 sales
ROE
−8%
return on equity
Operating margin
−9.5%
fiscal 2025, before interest and tax
Net margin
−10.8%
of revenue kept
Current ratio
5.12
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About 10x Genomics Inc

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium a…

Composite computed Nov 16, 2026 · peer basis: Technology (n=483) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 135 US ETFs · top wrappers by weightSee all ETFs holding TXG →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is 10x Genomics in?

10x Genomics is in the Technology sector and the Health Services industry.

What is 10x Genomics' Tenet Score?

10x Genomics' Tenet Score is 54 out of 100, ranked against 483 Technology peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.